A detailed history of Allspring Global Investments Holdings, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 1,229,558 shares of NTRA stock, worth $180 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,229,558
Previous 983,312 25.04%
Holding current value
$180 Million
Previous $106 Million 46.76%
% of portfolio
0.25%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$97.75 - $129.67 $24.1 Million - $31.9 Million
246,246 Added 25.04%
1,229,558 $156 Million
Q2 2024

Jul 26, 2024

BUY
$85.28 - $112.6 $10.2 Million - $13.5 Million
119,906 Added 13.89%
983,312 $106 Million
Q1 2024

Apr 18, 2024

BUY
$59.21 - $92.9 $8.48 Million - $13.3 Million
143,246 Added 19.89%
863,406 $79 Million
Q4 2023

Jan 25, 2024

BUY
$37.55 - $62.64 $6.01 Million - $10 Million
159,993 Added 28.56%
720,160 $45.1 Million
Q3 2023

Oct 27, 2023

BUY
$43.4 - $62.52 $24.3 Million - $35 Million
560,167 New
560,167 $24.8 Million
Q2 2023

Jul 18, 2023

BUY
$47.08 - $55.16 $1.08 Million - $1.26 Million
22,886 Added 4.02%
591,721 $28.8 Million
Q1 2023

Apr 13, 2023

BUY
$36.57 - $58.29 $20.7 Million - $33 Million
566,127 Added 20905.72%
568,835 $31.6 Million
Q4 2022

Jan 23, 2023

SELL
$34.17 - $47.91 $4.39 Million - $6.15 Million
-128,441 Reduced 97.94%
2,708 $0
Q3 2022

Oct 26, 2022

BUY
$36.93 - $56.68 $4.84 Million - $7.43 Million
131,149 New
131,149 $5.75 Million
Q2 2022

Jul 25, 2022

SELL
$28.13 - $44.54 $76,344 - $120,881
-2,714 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$30.32 - $91.33 $123 Million - $371 Million
-4,056,960 Reduced 99.93%
2,714 $110,000
Q4 2021

Jan 28, 2022

BUY
$86.26 - $119.0 $350 Million - $483 Million
4,059,674 New
4,059,674 $379 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.